Home

Nigeria's Immunization Funding Transition Plan to Replace Gavi: Podcast Launched

The Global Health Advocacy Incubator spotlights Nigeria's search for sustainable vaccine financing in a new podcast episode, as the country prepares to transition from Gavi support by 2028.

-- With Gavi support set to end in 2028, Nigeria is exploring new domestic financing models to close a projected $200 million annual funding gap for its immunization programs. The Global Health Advocacy Incubator (GHAI) has launched a new podcast episode to examine the policy and fiscal solutions under consideration.

More details can be found at https://www.advocacyincubator.org/one-shot-long-life/episode-1-nigeria-beyond-gavis-immunization-financing-support

The debut episode of One Shot, Long Life! features Nigerian health advocates and policy experts discussing the country's immunization landscape, fiscal constraints, and long-term sustainability plans. Host Abel Akara Ticha is joined by Chika Offor of the Vaccine Network for Disease Control and Professor Emmanuel Alhassan, GHAI's Nigeria Country Coordinator.

Nigeria has increased government contributions toward immunization from 14% in 2017 to 65% in 2022. However, these allocations still represent less than 5% of total health expenditure. The country's proposed model includes federal government coverage of 52% of vaccine procurement costs, with states expected to scale up their financial commitments through novel revenue streams.

The episode outlines innovative strategies under consideration, including the establishment of a first-line charge mechanism for the health budget and the development of local vaccine production capacity. Nigeria is also evaluating new revenue generation approaches, such as a proposed 9% Communication Service Tax on electronic service fees. If implemented, the tax could contribute significant monthly income. Additional proposals include tiered levies on sectors such as telecommunications, aviation, hospitality, alcohol, tobacco, and sugar-sweetened beverages.

The discussion also examines the challenges associated with the transition. Without adequate preparation, Nigeria may lose access to subsidized vaccines, favorable pricing arrangements, and technical assistance—factors that could reverse immunization gains and place additional strain on the national health system.

"This episode examines the economic realities behind vaccine funding and the urgent need to secure sustainable domestic financing," said a GHAI representative. "Nigeria's path forward will impact immunization equity for over 2.2 million zero-dose children."

About the Global Health Advocacy Incubator

The Global Health Advocacy Incubator partners with civil society organizations, governments, and policymakers to drive public health progress through legal and policy change. Based in Washington, D.C., the organization has supported health policy victories affecting over 4 billion people across 32 countries. GHAI provides advocacy strategy, communications support, capacity building, and research services to strengthen public health systems globally.

For more information or to listen to the full podcast, visit https://www.advocacyincubator.org/one-shot-long-life/episode-1-nigeria-beyond-gavis-immunization-financing-support

Contact Info:
Name: Jen Patterson
Email: Send Email
Organization: Global Health Advocacy Incubator
Address: 1400 I Street Northwest Suite 1200, Washington, DC 20005, United States
Website: https://www.advocacyincubator.org/

Source: PressCable

Release ID: 89167777

Should you come across any errors, concerns, or inconsistencies within this press release's content, we urge you to reach out without delay by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our committed team will promptly address your feedback within 8 hours and take appropriate measures to resolve any identified issues or guide you through the removal process. Providing accurate and dependable information remains our utmost priority.